Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cost Comparison Between Apixaban and Low Molecular Weight Heparin (LMWH) Among Venous Thromboembolism (VTE) Cancer Patients

NCT05643885 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05643885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05643885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cost Comparison Between Apixaban and Low Molecular Weight Heparin (LMWH) Among Venous Thromboembolism (VTE) Cancer Patients
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
August 31, 2022
Completion date
August 30, 2024
Enrollment
7,304 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thromboembolism